This webinar is critical for companies conducting clinical trials or selling products abroad. The consequences of violating the Foreign Corrupt Practices Act (FCPA) have never been higher. Companies have been compelled to pay record-setting multimillion-dollar penalties and senior-level executives have been prosecuted and fired. In recent years, the scope and reach of the FCPA has grown at a remarkable pace.
Carlos Ortiz, J.D. is a seasoned trial lawyer with extensive white collar experience. He is a shareholder at LeClairRyan where he is the head of the firm’s FCPA practice area team. Before joining LeClairRyan he was at DLA Piper where he served as the Vice-Chair of the firm’s FCPA and Compliance Group. Before entering private practice Mr. Ortiz had a distinguished 15 year prosecutorial career at the Department of Justice Tax Division and at the United States Attorney’s Office for the District of New Jersey where he served as Deputy and Acting Chief of the Criminal Division. Mr. Ortiz has conducted numerous domestic and international internal investigations on behalf of companies and he has extensive experience representing corporations and individuals before enforcement and regulatory agencies in connection with FCPA matters. His practice includes advising corporations, their boards of directors and their committees, in connection with corporate governance and compliance matters. Mr. Ortiz was honored at the White House for his work in leading as a prosecutor of a global financial investigation resulting in the breakup of a massive international network of internet-based commercial money laundering.
This post was made using the Auto Blogging Software from WebMagnates.org This line will not appear when posts are made after activating the software to full version.
No comments:
Post a Comment